Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benz- ylidene]-thiomorpholin-3-one, and use of same.

 
Web www.patentalert.com

< Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent

< New compounds

> Naphthaline derivatives as H3 inverse agonists

> Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

~ 00232